Autoimmune/inflammatory syndrome induced by adjuvants (ASIA), medical treatment of severe systemic compromise: case report
Main Article Content
Case description:
42-year-old woman with severe pulmonary and mediastinal inflammatory involvement, secondary to infiltration of a silicone-related allogenic material with systemic migration.
Clinical findings:
The patient developed esophageal and bronchial stenosis, recurrent infections, malnutrition, and respiratory deterioration, making surgical removal of the allogenic material impossible.
Treatment and outcome:
Clinical and radiological improvement was achieved after treatment with multiple intravenous and oral immunomodulators.
Clinical relevance:
Autoimmune/inflammatory syndrome induced by adjuvants (ASIA) is a heterogeneous disease that results from exposure to allogenic substances in a subject with genetic susceptibility. These substances induce autoimmune or autoinflammatory phenomena. ASIA was recently described, and its diagnostic criteria are still under discussion. The prognosis of this syndrome is not clear, and its treatment is based on the elimination of the causing substance; however, this often does not improve the patient’s condition, and it is necessary to initiate immunomodulatory treatment. The treatment used in this patient was not previously described in the literature.
- Biopolymer
- autoimmunity
- immunomodulation
- ASIA syndrome
- Silicones
- Foreign Bodies
- Dimethylpolysiloxanes
Siregar S, Groenwold RH, de Mol BA, Speekenbrink RG, Versteegh MI, Brandon Bravo Bruinsma GJ, et al. Evaluation of cardiac surgery mortality rates: 30-day mortality or longer follow-up. European Journal of Cardio-Thoracic Surgery. 2013 ;44:875-83. https://doi.org/10.1093/ejcts/ezt119 PMid:23471150 DOI: https://doi.org/10.1093/ejcts/ezt119
Bhukal I, Solanki SL, Ramaswamy S, Yaddanapudi LN, Jain A, Kumar P. Perioperative predictors of morbidity and mortality following cardiac surgery under cardiopulmonary bypass. Saudi J Anaesth. 2012;6:242-7. https://doi.org/10.4103/1658-354X.101215 PMid:23162397 PMCid:PMC3498662 DOI: https://doi.org/10.4103/1658-354X.101215
Hote M. Cardiac surgery risk scoring systems: In quest for the best. Heart Asia 2018;10: e011017. https://doi.org/10.1136/heartasia-2018-011017 PMid:29637928 PMCid:PMC5890060 DOI: https://doi.org/10.1136/heartasia-2018-011017
Nashef SA, Roques F, Michel P, Gauducheau E, Lemeshow S, Salamon R. European system for cardiac operative risk evaluation (EuroSCORE). Eur J Cardiothorac Surg. 1999; 16:9-13. https://doi.org/10.1016/S1010-7940(99)00134-7 PMid:10456395 DOI: https://doi.org/10.1016/S1010-7940(99)00134-7
Nashef SAM, Roques F, Michel P, Gauducheau E, De Vnicentiis C, Baudet E, et al. Risk factors and outcome in European cardiac surgery: analysis of the EuroSCORE multinational database of 19030 patients. Eur J Cardiothorac Surg. 1999; 15:816-22. https://doi.org/10.1016/S1010-7940(99)00106-2 PMid:10431864 DOI: https://doi.org/10.1016/S1010-7940(99)00106-2
Downloads
- Fabio E Ospina, Alex Echeverri, Iván Posso-Osorio, Lina Jaimes, Jaiber Gutierrez, Gabriel Jaime Tobón, Bevacizumab as a treatment for hereditary hemorrhagic telangiectasia in children: a case report , Colombia Medica: Vol. 48 No. 2 (2017)
- Luz Fernanda Sua, Nhora María Silva, Report of the first case of myxoid liposarcoma in Colombia: a rare tumor , Colombia Medica: Vol. 41 No. 3 (2010)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
The copy rights of the articles published in Colombia Médica belong to the Universidad del Valle. The contents of the articles that appear in the Journal are exclusively the responsibility of the authors and do not necessarily reflect the opinions of the Editorial Committee of the Journal. It is allowed to reproduce the material published in Colombia Médica without prior authorization for non-commercial use